London, United Kingdom, January 07, 2022 –(PR.com)– The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.

SMi Group is delighted to announce the 13th Annual Conference RNA Therapeutics, taking place on the 9th and 10th February 2022 in London, UK. The 2022 Conference theme is on the latest advances and opportunities in RNA-based medicine.

With only five weeks to go, visit www.therapeutics-rna.com/PR4PRCOM to register your attendance.

Ahead of the conference, SMi Group caught up with Nagy Habib, Head of HBP Surgery and Co-Founder, Imperial College London and MiNA…